共 15 条
[3]
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapoc (ICA-17043)
[J].
BRITISH JOURNAL OF HAEMATOLOGY,
2011, 153 (01)
:92-104
[6]
Garneau L, 2010, METHOD ENZYMOL, V485, P437, DOI [10.1016/S0076-6879(10)85024-4, 10.1016/B978-0-12-381296-4.00024-5]